Survival analysis from the CALGB trial of lenalidomide (LEN) maintenance therapy in newly diagnosed multiple myeloma (NDMM) post-autologous stem cell transplant (ASCT), adjusting for crossover (Alliance)
- Citation:
- Blood vol 132 (Suppl 1) 4737
- Meeting Instance:
- ASH 2018
- Year:
- 2018
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Celgene
- Grants:
- U10CA180821, U10CA180882, U10CA180820
- Corr. Author:
- Authors:
- Philip L. McCarthy Vera Suman Miranda Cooper Owain Saunders Paul Richardson Sujith Dhanasiri Sergio Giralt Ken Anderson Ed Stadtmauer Sarah A. Holstein
- Networks:
- LAPS-MA036, LAPS-NY016, LAPS-NY158, NE003
- Study
- CALGB-100104
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: